The speakers discuss the IRA, including its impacts on innovation, competition, and pricing in the life sciences industry.
Celeste Saravia of Cornerstone Research joined DLA Piper’s podcast, Pricing Rules, to discuss antitrust considerations from the implementation of the Inflation Reduction Act (IRA). Dr. Saravia spoke about the potential long-term effects of the IRA, such as changes in incentives for price-setting behavior as well as investments into new drug development. She also discussed bundled discounts in the pharmaceutical industry, noting a lack of uniformity in standards across circuit courts when they evaluate whether a bundled discount is an anticompetitive attempt to foreclose a rival.
Episode details are available on DLA Piper’s website.
The views expressed herein do not necessarily represent the views of Cornerstone Research.
San Francisco
